Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1982-3-22
pubmed:abstractText
Lysates of secretory granules from rat pituitary neurointermediate lobes were incubated with [3H]arginine- or [3H]phenylalanine-labeled toad pro-opiocortin. The processed products formed were identified by immunoprecipitation with adrenocorticotropin (ACTH) and endorphin antisera and by migration behavior on acid/urea/polyacrylamide gels. Pro-opiocortin was cleaved by the proteolytic activity in the secretory granule fraction to approximately 21,000 Mr ACTH, approximately 13,000 Mr ACTH, alpha-melanotropin, 16,000 Mr NH2-terminal glycopeptide, beta-lipotropin, and an endorphin-related peptide. Characterization of this pro-opiocortin-converting activity shows that it (i) is present in membrane and soluble fractions of the granule lysates, (ii) has a pH optimum of 5.0, (iii) appears to cleave at pairs of basic amino acid residues in the precursor, and (iv) is inhibited by leupeptin, pepstatin A, and p-chloromercuribenzoate but not diisopropyl fluorophosphate, N alpha-p-tosyl-L-lysine chloromethyl ketone hydrochloride, chloroquine, or EDTA. These inhibitor studies suggest that the converting-enzyme activity is due to an acid thiol, arginyl protease, distinct from any known cathepsin B-like activity.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-180016, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-197529, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-210798, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-218221, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-221818, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-222574, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-224038, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-228277, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-238361, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-391762, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-4352887, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-4607946, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-5010089, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-5444, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-5459480, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6108270, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6245851, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6255992, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6263594, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6264438, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6972377, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-6994549, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-7026570, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-7283132, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-7428696, http://linkedlifedata.com/resource/pubmed/commentcorrection/6275379-858741
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
79
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
108-12
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Characterization of pro-opiocortin-converting activity in purified secretory granules from rat pituitary neurointermediate lobe.
pubmed:publicationType
Journal Article